Nefrotic syndrome - Causes, Treatment & When to See a Doctor

```html

What is Nephrotic Syndrome?

Nephrotic syndrome (also spelled “nefrotic”) is a collection of signs that result from heavy protein loss in the urine (proteinuria) due to damage to the filtering units of the kidneys called glomeruli. The classic “nephrotic picture” includes:

• Proteinuria ≥ 3.5 g per 24 hours (or a urine protein‑to‑creatinine ratio ≥ 0.3 g/g)
• Hypoalbuminemia (low blood albumin, usually < 3 g/dL)
• Peripheral edema (swelling, often first seen around the eyes and ankles)
• Hyperlipidemia (elevated blood cholesterol and triglycerides)

These changes disrupt fluid balance and lead to the characteristic swelling and increased risk of blood clots and infections. Nephrotic syndrome can affect children, adults, or the elderly, and the underlying cause determines the long‑term outlook.

Common Causes

Nephrotic syndrome is not a disease itself but a manifestation of underlying kidney pathology. The most frequent culprits are:

• Minimal Change Disease (MCD) – the leading cause in children; kidneys look normal under a microscope but lose the ability to hold protein.
• Focal Segmental Glomerulosclerosis (FSGS) – scarring in parts of some glomeruli; common in adults and in people of African descent.
• Membranous Nephropathy – thickened glomerular basement membrane; a frequent cause in middle‑aged adults.
• Diabetic Nephropathy – chronic high blood sugar damages glomeruli; the most common cause of nephrotic syndrome in the United States.
• Lupus Nephritis (Systemic Lupus Erythematosus) – immune‑complex deposition leads to protein loss.
• Amyloidosis – abnormal protein (amyloid) deposits in kidney tissue.
• Infections – e.g., HIV, hepatitis B/C, syphilis, and malaria can trigger a nephrotic picture.
• Drugs & Toxins – non‑steroidal anti‑inflammatory drugs (NSAIDs), gold salts, and certain antibiotics.
• Congenital or hereditary disorders – such as Alport syndrome or Finnish type nephrosis.
• Malignancies – especially solid tumors (e.g., lung, colon) or hematologic cancers (e.g., Hodgkin lymphoma).

Associated Symptoms

Because the syndrome involves loss of protein and changes in blood lipids, patients often experience a range of related signs:

• Edema – swelling of the face (especially around the eyes), hands, abdomen (ascites), and legs.
• Foamy or frothy urine – due to excess protein spilling into the urine.
• Weight gain – from fluid retention, not from fat.
• Fatigue & weakness – low albumin affects transport of hormones and drugs.
• Hyperlipidemia‑related symptoms – xanthomas (yellowish skin deposits) can appear on elbows or knees.
• Frequent infections – loss of immunoglobulins predisposes to bacterial pneumonia, cellulitis, and peritonitis.
• Blood clots (thrombosis) – especially in the deep veins of the legs or renal veins.
• Foam‑filled ascites or pleural effusion – large fluid collections in the abdomen or chest.

When to See a Doctor

Prompt evaluation is essential because untreated nephrotic syndrome can lead to severe complications. Seek medical care if you notice:

• Rapidly increasing swelling, especially if it spreads to the abdomen or chest.
• Sudden, sharp pain in the calf, groin, or abdomen (possible blood clot).
• Fever, chills, or worsening cough – signs of infection.
• Persistent foamy urine or noticeable darkening of urine.
• Shortness of breath or difficulty breathing.
• Unexplained weight gain (>5 kg) over a few days.

Diagnosis

Diagnosing nephrotic syndrome involves confirming heavy proteinuria and identifying the underlying cause.

Laboratory Tests

• Urine protein quantification – 24‑hour urine collection or spot urine protein‑to‑creatinine ratio.
• Serum albumin and total protein – low levels confirm hypoalbuminemia.
• Lipid panel – cholesterol and triglycerides are usually elevated.
• Renal function tests – serum creatinine and eGFR assess kidney filtration.
• Serologic work‑up – ANA, anti‑dsDNA, complement levels (for lupus); hepatitis B/C, HIV serology; anti‑PLA2R antibodies (membranous nephropathy).
• Coagulation profile – PT/INR, aPTT, and D‑dimer if clot risk is suspected.

Imaging

• Renal ultrasound – evaluates kidney size, structure, and rules out obstruction.
• Chest X‑ray or CT – checks for pleural effusion or pulmonary embolism if symptoms suggest.

Kidney Biopsy

In adults (and sometimes older children) a percutaneous kidney biopsy is often performed to pinpoint the exact disease (e.g., membranous nephropathy vs. FSGS). The tissue is examined with light microscopy, immunofluorescence, and electron microscopy.

Treatment Options

Treatment is two‑pronged: (1) control the underlying disease and (2) manage the complications of protein loss.

Medical Therapies

• Corticosteroids – first‑line for minimal change disease and many cases of FSGS; typical regimens start with prednisone 1 mg/kg/day.
• Immunosuppressants – cyclophosphamide, calcineurin inhibitors (cyclosporine, tacrolimus), mycophenolate mofetil, or rituximab for steroid‑resistant or relapsing disease.
• ACE inhibitors or ARBs – lower proteinuria and protect kidney function by reducing intraglomerular pressure.
• Diuretics – loop diuretics (furosemide) or thiazides to reduce edema; combine with a low‑sodium diet for best effect.
• Statins – recommended when LDL cholesterol ≥ 100 mg/dL to lower cardiovascular risk.
• Anticoagulation – considered in patients with serum albumin < 2.0 g/dL or a documented thrombus; low‑molecular‑weight heparin or warfarin is typical.
• Vitamin D & calcium supplementation – to counteract steroid‑induced bone loss and hypo‑albuminemia‑related deficits.
• Vaccinations – pneumococcal, influenza, and hepatitis B vaccines reduce infection risk.

Home & Lifestyle Measures

• Low‑sodium diet – < 2 g of salt per day (≈ ½ tsp) helps control edema.
• Fluid restriction – usually 1.5–2 L per day if severe edema or heart failure is present.
• Protein intake – moderate (0.8–1.0 g/kg/day) to avoid malnutrition while not overloading kidneys.
• Weight‑bearing exercise – 150 minutes of moderate activity per week improves lipid profile and cardiovascular health.
• Smoking cessation – dramatically lowers cardiovascular and clotting risk.
• Monitor urine output – keep a daily log of volume and any foamy appearance.

Prevention Tips

While many causes (e.g., genetic diseases) cannot be prevented, several strategies lower the risk of developing nephrotic syndrome or its complications:

• Maintain good control of diabetes and hypertension – the two biggest modifiable risk factors for kidney disease.
• Adopt a heart‑healthy diet rich in fruits, vegetables, whole grains, and lean protein; limit saturated fats and processed foods.
• Stay up‑to‑date with vaccinations to reduce infection‑related kidney injury.
• Avoid nephrotoxic medications when possible; if NSAIDs or certain antibiotics are needed, use the lowest effective dose for the shortest time.
• Regular medical follow‑up for known autoimmune diseases (lupus, vasculitis) to catch renal involvement early.
• Screen for and treat chronic viral infections (HBV, HCV, HIV) promptly.
• Do not smoke and limit alcohol intake – both worsen lipid abnormalities and increase clot risk.

Emergency Warning Signs

References

• Mayo Clinic. Nephrotic syndrome. https://www.mayoclinic.org/diseases-conditions/nephrotic-syndrome/diagnosis-treatment/drc-20375646 (accessed May 2026).
• National Kidney Foundation. Clinical Practice Guideline for Glomerular Diseases. https://www.kidney.org/professionals/guidelines/glomerulardiseases (2023).
• Cleveland Clinic. Focal Segmental Glomerulosclerosis (FSGS). https://my.clevelandclinic.org/health/diseases/17073-fsgs (2025).
• American Diabetes Association. Standards of Care in Diabetes—2024. Diabetes Care. 2024;47(Suppl 1):S1‑S184.
• World Health Organization. Guidelines on the Management of Chronic Kidney Disease. WHO Press, 2022.
• Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2024 Clinical Practice Guideline for Glomerular Diseases. Kidney Int Suppl. 2024;14(1):1‑95.

```